↓ Skip to main content

Enhanced oncolysis mediated by Coxsackievirus A21 in combination with doxorubicin hydrochloride

Overview of attention for article published in Investigational New Drugs, December 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
58 Mendeley
Title
Enhanced oncolysis mediated by Coxsackievirus A21 in combination with doxorubicin hydrochloride
Published in
Investigational New Drugs, December 2010
DOI 10.1007/s10637-010-9614-0
Pubmed ID
Authors

Kathryn A. Skelding, Richard D. Barry, Darren R. Shafren

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Colombia 1 2%
Unknown 56 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 21%
Student > Ph. D. Student 11 19%
Researcher 10 17%
Student > Bachelor 6 10%
Other 3 5%
Other 7 12%
Unknown 9 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 13 22%
Medicine and Dentistry 9 16%
Biochemistry, Genetics and Molecular Biology 7 12%
Psychology 3 5%
Immunology and Microbiology 3 5%
Other 11 19%
Unknown 12 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2022.
All research outputs
#5,611,796
of 25,837,817 outputs
Outputs from Investigational New Drugs
#192
of 1,270 outputs
Outputs of similar age
#35,077
of 195,758 outputs
Outputs of similar age from Investigational New Drugs
#1
of 19 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,270 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,758 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.